Ken Griffin’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.1M | Buy |
114,119
+95,661
| +518% | +$41M | 0.01% | 1506 |
|
|
2025
Q4 | $7.9M | Sell |
18,458
-42,674
| -70% | -$18.6M | ﹤0.01% | 3575 |
|
|
2025
Q3 | $27.4M | Buy |
61,132
+44,396
| +265% | +$20.1M | ﹤0.01% | 1966 |
|
|
2025
Q2 | $8.15M | Sell |
16,736
-31,555
| -65% | -$18M | ﹤0.01% | 3329 |
|
|
2025
Q1 | $29.7M | Sell |
48,291
-28,852
| -37% | -$16.4M | 0.01% | 1603 |
|
|
2024
Q4 | $40.9M | Buy |
77,143
+51,206
| +197% | +$28.9M | 0.01% | 1454 |
|
|
2024
Q3 | $15.6M | Sell |
25,937
-14,421
| -36% | -$8.18M | ﹤0.01% | 2329 |
|
|
2024
Q2 | $21.9M | Buy |
40,358
+14,403
| +55% | +$8.25M | ﹤0.01% | 1906 |
|
|
2024
Q1 | $16.7M | Buy |
25,955
+2,447
| +10% | +$1.49M | ﹤0.01% | 2282 |
|
|
2023
Q4 | $13.7M | Buy |
23,508
+9,354
| +66% | +$5.23M | ﹤0.01% | 2438 |
|
|
2023
Q3 | $7.36M | Buy |
14,154
+8,902
| +169% | +$4.63M | ﹤0.01% | 3085 |
|
|
2023
Q2 | $2.84M | Buy |
+5,252
| New | +$2.87M | ﹤0.01% | 4560 |
|
|
2023
Q1 | – | Sell |
-19,254
| Closed | -$9.83M | – | 14786 |
|
|
2022
Q4 | $9.83M | Buy |
19,254
+7,893
| +69% | +$3.84M | ﹤0.01% | 2870 |
|
|
2022
Q3 | $4.96M | Sell |
11,361
-3,740
| -25% | -$1.8M | ﹤0.01% | 3889 |
|
|
2022
Q2 | $7.09M | Buy |
15,101
+7,086
| +88% | +$3.46M | ﹤0.01% | 3185 |
|
|
2022
Q1 | $4.06M | Sell |
8,015
-6,119
| -43% | -$2.93M | ﹤0.01% | 4575 |
|
|
2021
Q4 | $7.48M | Sell |
14,134
-7,195
| -34% | -$3.45M | ﹤0.01% | 3590 |
|
|
2021
Q3 | $9.92M | Sell |
21,329
-4,572
| -18% | -$2.16M | ﹤0.01% | 3094 |
|
|
2021
Q2 | $12.3M | Sell |
25,901
-93,230
| -78% | -$44.8M | ﹤0.01% | 2766 |
|
|
2021
Q1 | $54.8M | Sell |
119,131
-3,093
| -3% | -$1.52M | 0.01% | 981 |
|
|
2020
Q4 | $65.1M | Buy |
122,224
+48,776
| +66% | +$24M | 0.02% | 782 |
|
|
2020
Q3 | $35.3M | Buy |
+73,448
| New | +$36M | 0.01% | 1096 |
|
|
2020
Q2 | – | Sell |
-59,489
| Closed | -$25.8M | – | 9832 |
|
|
2020
Q1 | $25.8M | Sell |
59,489
-58,508
| -50% | -$26.1M | 0.01% | 1044 |
|
|
2019
Q4 | $51.8M | Buy |
117,997
+14,536
| +14% | +$6.11M | 0.02% | 752 |
|
|
2019
Q3 | $43.2M | Buy |
103,461
+5,248
| +5% | +$2.14M | 0.02% | 846 |
|
|
2019
Q2 | $35.4M | Buy |
98,213
+82,921
| +542% | +$27.7M | 0.02% | 948 |
|
|
2019
Q1 | $4.89M | Sell |
15,292
-2,722
| -15% | -$836K | ﹤0.01% | 3034 |
|
|
2018
Q4 | $5.1M | Sell |
18,014
-35,291
| -66% | -$10.7M | ﹤0.01% | 2758 |
|
|
2018
Q3 | $17M | Sell |
53,305
-10,785
| -17% | -$3.44M | 0.01% | 1546 |
|
|
2018
Q2 | $20.6M | Buy |
+64,090
| New | +$20.1M | 0.01% | 1286 |
|
|
2017
Q3 | – | Sell |
-9,233
| Closed | -$1.89M | – | 7564 |
|
|
2017
Q2 | $1.89M | Buy |
9,233
+4,675
| +103% | +$931K | ﹤0.01% | 3236 |
|
|
2017
Q1 | $833K | Buy |
4,558
+3,015
| +195% | +$526K | ﹤0.01% | 4265 |
|
|
2016
Q4 | $248K | Buy |
+1,543
| New | +$227K | ﹤0.01% | 5952 |
|
|
2016
Q3 | – | Sell |
-3,412
| Closed | -$465K | – | 7262 |
|
|
2016
Q2 | $465K | Buy |
+3,412
| New | +$453K | ﹤0.01% | 4583 |
|
|
2014
Q4 | – | Sell |
-11,721
| Closed | -$1.21M | – | 8496 |
|
|
2014
Q3 | $1.21M | Buy |
+11,721
| New | +$1.19M | ﹤0.01% | 3478 |
|
|
2014
Q2 | – | Sell |
-419
| Closed | -$37K | – | 7974 |
|
|
2014
Q1 | $37K | Sell |
419
-22,757
| -98% | -$1.85M | ﹤0.01% | 6955 |
|
|
2013
Q4 | $1.77M | Buy |
23,176
+13,394
| +137% | +$988K | ﹤0.01% | 2653 |
|
|
2013
Q3 | $699K | Sell |
9,782
-83,009
| -89% | -$5.91M | ﹤0.01% | 3466 |
|
|
2013
Q2 | $6.72M | Buy |
+92,791
| New | +$6.81M | 0.01% | 1318 |
|
Other funds holding CHE
VPM
VCM
Ken Griffin's CHE Position: Q1 2026 in Review
Ken Griffin increased its Chemed (CHE) stake by 518% in Q1 2026, buying an estimated $41M and bringing the position to 114,119 shares worth $43.1M. The position accounts for 0.01% of the portfolio, ranked #1506.
Ken Griffin first reported a position in CHE in Q2 2013 and has held it in 39 quarters since. The position peaked at $65.1M in Q4 2020. 490 funds tracked by Wall St. Rank hold CHE as of Q1 2026.
- Ken Griffin held 114,119 shares of Chemed worth $43.1M as of Q1 2026.
- Ken Griffin bought 95,661 Chemed shares in Q1 2026, an estimated $41M.
- Chemed made up 0.01% of Ken Griffin's portfolio in Q1 2026, its #1506 holding.
- Ken Griffin first reported a position in Chemed in Q2 2013 and has held it in 39 quarters since.
- Ken Griffin's Chemed position peaked at $65.1M in Q4 2020.
- 490 funds tracked by Wall St. Rank held Chemed as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.